News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CNS Response CEO George Carpenter to Present at the Rodman & Renshaw 13th Annual Healthcare Conference


9/1/2011 8:53:58 AM

ALISO VIEJO, CA--(Marketwire - September 01, 2011) - CNS Response, Inc. (OTCBB: CNSO) today announced that CEO George Carpenter will be presenting at the Rodman & Renshaw 13th Annual Healthcare Conference to be held on September 11 - 13, 2011, at the Waldorf Astoria Hotel in New York, NY. Mr. Carpenter's presentation is scheduled for Tuesday, September 13 at 4:30 p.m. Eastern in the hotel's Starlight Center.

One-on-one meetings with Mr. Carpenter can be scheduled by conference attendees through the Rodman & Renshaw conference website, http://www.rodmanandrenshaw.com.

To access the live and subsequently archived webcast of the presentation, visit the Investor Relations section of the CNS Response website at http://www.cnsresponse.com, or at http://www.wsw.com/webcast/rrshq20/cnso. Please connect to the website at least 15 minutes prior to the presentation to allow for any necessary software downloads. An archived replay will be available for 90 days beginning 24 hours after the live presentation.

About CNS Response
CNS Response provides reference data and analytic tools for clinicians and researchers in psychiatry. While treatment for mental disorders has doubled in the last 20 years, it is estimated that 17 million Americans have failed two or more medication therapies for their mental disorder. The company recently launched the Psychiatric EEG Evaluation Registry, or PEER Online™, a new registry and reporting platform that allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through an EEG. PEER Online builds on the company's original physician-developed database, Referenced-EEG® (rEEG®). Avoiding trial and error pharmacotherapy, the dominant approach for psychiatric treatment, is the objective of PEER Online™.

To read more about the benefits of this patented technology for patients, physicians and payers, please visit www.cnsresponse.com. Medical professionals interested in learning more can contact CNS Response at PEERinfo@cnsresponse.com.


Investor Relations:
Marty Tullio
Managing Partner
McCloud Communications, LLC
949.553.9748
Email Contact

Media Relations:
Joyce Johannson
Johannson Communications
612.927.4543 (office)
612.845.3080 (cell)
Email Contact


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES